GL1X · GenesisL1 explorer

MolNFT v1 · #106017 · protein

Human SIRT2 in complex with SIRREAL1 and ac-lys-otc peptide

4RMI · NAD-dependent protein deacetylase sirtuin-2: “Human SIRT2 in complex with SIRREAL1 and ac-lys-otc peptide”. X-ray diffraction, 2 ligands (3TK, ZN), 2 pockets (best druggability 0.76). MolNFT v1 #106017 on GenesisL1: 3D structure…

PDB
4RMI
Type
protein
Length
281 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-2; Ac-lys-otc peptide
EC
3.5.1.-
UniProt
Q8IXJ6
Ligands
3TK, ZN
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-)protein27837% helix, 18% strandQ8IXJ6
BAc-lys-otc peptideprotein30% helix, 0% strand—

Ligands and binding sites

  • 3TK · N-(5-benzyl-1,3-thiazol-2-yl)-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide · ligand · chains A, B
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14600.760.84553TK
2970.350.7426empty

Interfaces

1 interface between chains.

  • A–B · 393 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (acetylation).

Compared structures

  • 4RMI · Human Sirt2 in complex with SirReal1 and Ac-Lys-OTC peptide · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8IXJ6 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-2 (Q8IXJ6) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.